Getinge AB (publ) (GETI-B.ST)
SEK 174.85
(2.01%)
SEK 174.85
(2.01%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.81 Billion SEK | 5.18% |
| 2022 | 3.62 Billion SEK | -17.04% |
| 2021 | 4.37 Billion SEK | -8.63% |
| 2020 | 4.78 Billion SEK | 101.69% |
| 2019 | 2.37 Billion SEK | 935.21% |
| 2018 | -284 Million SEK | -119.02% |
| 2017 | 1.49 Billion SEK | -34.72% |
| 2016 | 2.28 Billion SEK | -16.2% |
| 2015 | 2.72 Billion SEK | 3.14% |
| 2014 | 2.64 Billion SEK | -29.4% |
| 2013 | 3.74 Billion SEK | -6.44% |
| 2012 | 4 Billion SEK | 2.09% |
| 2011 | 3.92 Billion SEK | 6.37% |
| 2010 | 3.68 Billion SEK | 20.16% |
| 2009 | 3.07 Billion SEK | 6.71% |
| 2008 | 2.87 Billion SEK | 26.07% |
| 2007 | 2.28 Billion SEK | 17.87% |
| 2006 | 1.93 Billion SEK | 7.39% |
| 2005 | 1.8 Billion SEK | 3.47% |
| 2004 | 1.74 Billion SEK | 238.67% |
| 2003 | -1.25 Billion SEK | -19.72% |
| 2002 | -1.04 Billion SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 906 Million SEK | 20.0% |
| 2024 Q3 | 184 Million SEK | -79.69% |
| 2024 Q1 | 755 Million SEK | -40.83% |
| 2023 Q1 | 901 Million SEK | 8.82% |
| 2023 Q4 | 1.27 Billion SEK | -2.97% |
| 2023 Q3 | 1.31 Billion SEK | 243.34% |
| 2023 Q2 | 383 Million SEK | -57.49% |
| 2023 FY | 3.81 Billion SEK | 5.18% |
| 2022 Q2 | 911 Million SEK | 16.79% |
| 2022 Q1 | 780 Million SEK | -29.86% |
| 2022 FY | 3.62 Billion SEK | -17.04% |
| 2022 Q4 | 828 Million SEK | -25.2% |
| 2022 Q3 | 1.1 Billion SEK | 21.51% |
| 2021 Q1 | 960 Million SEK | -40.34% |
| 2021 FY | 4.37 Billion SEK | -8.63% |
| 2021 Q2 | 1.2 Billion SEK | 25.52% |
| 2021 Q3 | 1.09 Billion SEK | -9.21% |
| 2021 Q4 | 1.11 Billion SEK | 1.65% |
| 2020 Q3 | 1.91 Billion SEK | 152.71% |
| 2020 FY | 4.78 Billion SEK | 101.69% |
| 2020 Q2 | 757 Million SEK | 49.9% |
| 2020 Q1 | 505 Million SEK | -65.81% |
| 2020 Q4 | 1.6 Billion SEK | -15.89% |
| 2019 Q4 | 1.47 Billion SEK | 241.11% |
| 2019 Q3 | 433 Million SEK | 33.64% |
| 2019 Q1 | 138 Million SEK | -88.58% |
| 2019 FY | 2.37 Billion SEK | 935.21% |
| 2019 Q2 | 324 Million SEK | 134.78% |
| 2018 Q3 | -1.73 Billion SEK | -528.64% |
| 2018 FY | -284 Million SEK | -119.02% |
| 2018 Q1 | -161 Million SEK | -130.38% |
| 2018 Q2 | 405 Million SEK | 351.55% |
| 2018 Q4 | 1.2 Billion SEK | 169.59% |
| 2017 Q4 | 530 Million SEK | 103.07% |
| 2017 Q3 | 261 Million SEK | 61.11% |
| 2017 FY | 1.49 Billion SEK | -34.72% |
| 2017 Q2 | 162 Million SEK | -70.0% |
| 2017 Q1 | 540 Million SEK | -62.73% |
| 2016 Q4 | 1.44 Billion SEK | 2857.14% |
| 2016 Q1 | 316 Million SEK | -79.55% |
| 2016 Q2 | 473 Million SEK | 49.68% |
| 2016 FY | 2.28 Billion SEK | -16.2% |
| 2016 Q3 | 49 Million SEK | -89.64% |
| 2015 FY | 2.72 Billion SEK | 3.14% |
| 2015 Q4 | 1.54 Billion SEK | 266.98% |
| 2015 Q3 | 421 Million SEK | -1.64% |
| 2015 Q2 | 428 Million SEK | 27.76% |
| 2015 Q1 | 335 Million SEK | -78.41% |
| 2014 Q1 | -294 Million SEK | -115.82% |
| 2014 FY | 2.64 Billion SEK | -29.4% |
| 2014 Q4 | 1.55 Billion SEK | 129.93% |
| 2014 Q3 | 675 Million SEK | -5.33% |
| 2014 Q2 | 713 Million SEK | 342.52% |
| 2013 Q4 | 1.85 Billion SEK | 159.86% |
| 2013 FY | 3.74 Billion SEK | -6.44% |
| 2013 Q3 | 715 Million SEK | -7.74% |
| 2013 Q2 | 775 Million SEK | 93.75% |
| 2013 Q1 | 400 Million SEK | -74.86% |
| 2012 Q2 | 865 Million SEK | 22.87% |
| 2012 Q3 | 847 Million SEK | -2.08% |
| 2012 Q4 | 1.59 Billion SEK | 87.84% |
| 2012 FY | 4 Billion SEK | 2.09% |
| 2012 Q1 | 704 Million SEK | -57.59% |
| 2011 Q3 | 805 Million SEK | 4.82% |
| 2011 FY | 3.92 Billion SEK | 6.37% |
| 2011 Q1 | 690 Million SEK | -81.0% |
| 2011 Q4 | 1.66 Billion SEK | 106.21% |
| 2011 Q2 | 768 Million SEK | 11.3% |
| 2010 Q3 | 6 Million SEK | -50.0% |
| 2010 Q2 | 12 Million SEK | -70.0% |
| 2010 Q1 | 40 Million SEK | -98.7% |
| 2010 FY | 3.68 Billion SEK | 20.16% |
| 2010 Q4 | 3.63 Billion SEK | 60416.67% |
| 2009 FY | 3.07 Billion SEK | 6.71% |
| 2009 Q3 | 804 Million SEK | 20000.0% |
| 2009 Q4 | 3.07 Billion SEK | 281.84% |
| 2009 Q1 | 521 Million SEK | 0.0% |
| 2009 Q2 | 4 Million SEK | -99.23% |
| 2008 FY | 2.87 Billion SEK | 26.07% |
| 2007 FY | 2.28 Billion SEK | 17.87% |
| 2006 FY | 1.93 Billion SEK | 7.39% |
| 2005 FY | 1.8 Billion SEK | 3.47% |
| 2004 FY | 1.74 Billion SEK | 238.67% |
| 2003 FY | -1.25 Billion SEK | -19.72% |
| 2002 FY | -1.04 Billion SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 5017.927% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -1168.796% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -1168.796% |
| Arcoma AB | 4.66 Million SEK | -81745.494% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 2990.861% |
| BICO Group AB (publ) | -618.3 Million SEK | 716.853% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | -9612.249% |
| CellaVision AB (publ) | 167.05 Million SEK | -2183.135% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 5884.66% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 12997.522% |
| C-Rad AB (publ) | 44.24 Million SEK | -8520.378% |
| Duearity AB (publ) | -25.76 Million SEK | 14904.177% |
| Dignitana AB (publ) | -15.02 Million SEK | 25482.67% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 4123.207% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 5672.286% |
| Iconovo AB (publ) | -45.77 Million SEK | 8431.738% |
| Integrum AB (publ) | 6.51 Million SEK | -58465.738% |
| Luxbright AB (publ) | -25.8 Million SEK | 14880.402% |
| Mentice AB (publ) | -679 Thousand SEK | 561808.395% |
| OssDsign AB (publ) | -91.95 Million SEK | 4247.636% |
| Paxman AB (publ) | 12.61 Million SEK | -30124.265% |
| Promimic AB (publ) | -9.11 Million SEK | 41929.349% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 2360.858% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 7170.951% |
| ScandiDos AB (publ) | -13.48 Million SEK | 28387.473% |
| Sectra AB (publ) | 518.49 Million SEK | -635.596% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 5918.725% |
| Senzime AB (publ) | -133.74 Million SEK | 2951.695% |
| SpectraCure AB (publ) | -21.35 Million SEK | 17963.332% |
| Stille AB | 44.95 Million SEK | -8384.606% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 206.269% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | -9804.95% |